{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:40:14Z","timestamp":1787244014973,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bmc.2021.116018","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T01:39:22Z","timestamp":1610933962000},"page":"116018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Quest for a potent antimalarial drug lead: Synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines"],"prefix":"10.1016","volume":"33","author":[{"given":"Yuki","family":"Mizukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ikegami-Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiki","family":"Sakanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nanga Chick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Tsubuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-5371","authenticated-orcid":false,"given":"Toyonobu","family":"Usuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116018_b0005","unstructured":"WHO World malaria report. The \u201cWorld malaria report 2019\u201d at a glance. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/world-malaria-report-2019 (accessed October 15, 2020)."},{"key":"10.1016\/j.bmc.2021.116018_b0010","unstructured":"Sun, J.; Konishi, Y.; Macina, T.; Kondo, N.; You, D. T. 4-Aminoquinazoline derivatives and pharmaceuticals containing the same. JP 2,657,760 (1997.06.06; Ono Pharmaceutical Co., Ltd.)."},{"key":"10.1016\/j.bmc.2021.116018_b0015","unstructured":"Campbell, S. F. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines. U.S. 4,188,390 (1980.02.12; Pfizer Inc.)."},{"key":"10.1016\/j.bmc.2021.116018_b0020","unstructured":"Matier, W. L. and Catt, J. D. 2-Piperazinyl-6,7-dimethoxyquinazolines. U.S. 4,060,615 (1977. 11.29; Mead Johnson & Company)."},{"key":"10.1016\/j.bmc.2021.116018_b0025","unstructured":"Hess, H-J. E. Use of 2,4-diaminoquinazolines as hypotensive agents. U.S. 3,663,706 (1972. 05.16; Pfizer Inc.)."},{"key":"10.1016\/j.bmc.2021.116018_b0030","unstructured":"Hess, H-J. E. Certain 6-and\/or alkoxy-substituted-2,4-bis(disubstitutedamino)-quinazolines. U.S. 3,635,979 (1972.01.18; Pfizer Inc.)."},{"key":"10.1016\/j.bmc.2021.116018_b0035","unstructured":"Hess, H-J. E. 2,4,6,7-Tetra substituted quinazolines. U.S. 3,511,836 (1970.05.12; Pfizer Inc.)."},{"key":"10.1016\/j.bmc.2021.116018_b0040","unstructured":"Mc Gowan, D.; Raboisson, P. J-M. B.; Jonckers, T. H. M.; Last, S. J.; Embrechts, W. and Pieters, S. M. A. Quinazoline derivatives as TLR modulators for the treatment of viral infections and further diseases and their preparation. WO 2012156498 (Janssen R&D Ireland, Ire.)."},{"key":"10.1016\/j.bmc.2021.116018_b0045","unstructured":"Beard, R. L.; Vuligonda, V.; Duong, T. T.; Vu, T.; Donello, J. E.; Garst, M. E. and Rodrigues, G. A. Preparation of quinazoline-2,4-diamino derivatives as CXCR4 receptor antagonists. WO 2009143058 (Allergan, Inc., USA)."},{"key":"10.1016\/j.bmc.2021.116018_b0050","doi-asserted-by":"crossref","unstructured":"Yokoyama, K.: Ishikawa, N.; Igarashi, S.; Kawano, N.; Hattori, K.; Miyazaki, T.; Ogino, S.; Matsumoto Y.; Takeuchi, M. and Ohta, M. Discovery of potent CCR4 antagonists: synthesis and structure-activity relationship study of 2,4-diamino-quinazolines. Bioorg. Med. Chem. 2008, 16, 7021-7032.","DOI":"10.1016\/j.bmc.2008.05.036"},{"key":"10.1016\/j.bmc.2021.116018_b0055","unstructured":"Coe, J. W.; Fliri, A. F. J.; Kaneko, T. and Larson, E. R. 2,4-Diaminoquinazolines derivatives enhancing antitumor activity. WO 199214716A1 (Pfizer Inc.)."},{"key":"10.1016\/j.bmc.2021.116018_b0060","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/acs.jmedchem.6b01645","article-title":"Discovery of potent and selective inhibitors for G9a-like protein (GLP) lysine methyltransferase","volume":"60","author":"Xiong","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2021.116018_b0065","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1021\/jm500871s","article-title":"Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8","volume":"57","author":"Ma","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2021.116018_b0070","unstructured":"Brown, R.; Fuchter M. J.; Chapman-Rothe, N.; Srimongkolpithak, N.; Caro, J.; Synder, J.; Ganesh, T.; Liu, J. and Sun, A. Preparation of quinazoline derivatives for use as histone lysine methyltransferase (HKMTase) EZH2 inhibitors. WO 2013140148 (Imperial Innovations Limited, UK; Emory University)."},{"key":"10.1016\/j.bmc.2021.116018_b0075","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jm5000408","article-title":"Antileishmanial activity of a series of N2, N4-disubstituted quinazoline-2,4-diamines","volume":"57","author":"Van Hern","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2021.116018_b0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/jm00134a002","article-title":"Synthesis and antimalarial effects of N2-aryl-N4-[(dialkylamino)alkyl]- and N4-Aryl-N2-[(dialkylamino)alkyl-2,4-quinazolinediamines","volume":"24","author":"Elslager","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2021.116018_b0085","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1128\/AAC.01526-09","article-title":"Preclinical evaluation of the antifolate QN254, 5-chloro-N\u20196\u2019-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate","volume":"4","author":"Nzila","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmc.2021.116018_b0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2021.116018_b0095","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cmdc.201402098","article-title":"Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds","volume":"9","author":"Sundriyal","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2021.116018_b0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1039\/C7MD00052A","article-title":"Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity","volume":"8","author":"Sundriyl","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2021.116018_b0105","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.6b01673","article-title":"Optimization of 2-anilino 4-amino substituted quinazolines into potent antimalarial agents with oral in vivo activity","volume":"60","author":"Gilson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2021.116018_b0110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmc.2021.116018_b0115","first-page":"50","article-title":"Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture","volume":"33","author":"Ponnudurai","year":"1981","journal-title":"Tropical Geograph. Med."},{"key":"10.1016\/j.bmc.2021.116018_b0120","first-page":"473","article-title":"A new fluorimetric assay for cytotoxicity measurements in vitro","volume":"268","author":"Page","year":"1993","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bmc.2021.116018_b0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H] thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.bmc.2021.116018_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nature Rev. Drug Discov."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:10:47Z","timestamp":1760836247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"alternative-id":["S0968089621000262"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116018","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quest for a potent antimalarial drug lead: Synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116018"}}